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Abstract
Academic journals increasingly request a full disclosure of financial conflict of interest (CoI).
The Committee for Publication Ethics provides editors with guidance about the course of
action in the case of suspected non-disclosure. No prior study has examined the extent to
which journal articles on psychosocial interventions disclose CoI, and how journal editors
process requests to examine suspected undisclosed CoI. Four internationally disseminated
psychosocial interventions were examined. 136 articles related to an intervention, co-
authored by intervention developers and published in health sciences journals were
retrieved as requiring a CoI statement. Two editors refused consent to be included in the
study. COI disclosures and editor responses were coded for 134 articles. Overall, 92/134
(71%) of all articles were found to have absent, incomplete or partly misleading CoI disclo-
sures. Disclosure rates for the four programs varied significantly between 11% and 73%.
Journal editors were contacted about 92 published articles with no CoI disclosure or a dis-
closure that was considered problematic. In 65/92 (71%) of all cases the editors published
an ‘erratum’ or ‘corrigendum’. In 16 of these cases the journal had mishandled a submitted
disclosure. The most frequent reason for non-publication of an erratum was that the journal
had no disclosure policy at the time of the publication (16 cases). Consumers of research
on psychosocial interventions published in peer-reviewed journals cannot currently assume
that CoI disclosures are adequate and complete. More efforts are needed to achieve
transparency.
Introduction
Over the past decade clinicians and researchers have become progressively sensitized to the
potential for research to be biased due to financial conflicts of interest (CoI).[1–3] Much recent
concern relates to situations where pharmaceutical companies sponsor research about the
effectiveness of drugs.[4, 5] CoI associated with psychosocial interventions has received less
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attention. However, health services in many countries increasingly rely on commercially dis-
seminated psychosocial interventions that claim support by research evidence.[6] They play an
increasing role in officially approved selections of evidence-based interventions that address
conduct problems, substance use, or mental health issues.[7] Financial arrangements for such
interventions vary, but implementation often benefits the program developers. Mechanisms
include the ownership of companies that distribute the intervention, the receipt of royalties
and consulting fees, and the sponsorship of research by the disseminating organization.
Guidance by the Committee of Publication Ethics (COPE) for publishers and journal editors
is an important basis for improving research transparency and integrity. The Code of Conduct
published in 2003 specified that editors of journals which are members of COPE should have
systems in place that manage authors’ conflicts of interests. Hence author guidance in most
journals across the health sciences now requires a full disclosure of potential conflicts of inter-
ests. Also, COPE provides editors with guidance about the appropriate course of action when a
reader reports a suspected undisclosed CoI in a published article.[8]
This article examines papers published in peer-reviewed journals and co-authored by the
developer of one of four major internationally disseminated psychosocial interventions
addressing parenting: The Triple P (Positive Parenting Program) program developed by Mat-
thew Sanders,[9] the early home-visiting program, Nurse-Family Partnership by David Olds,
[10] the parenting and social skills program Incredible Years by Carolyn Webster Stratton,[11]
and the therapeutic intervention primarily for youth offendersMulti-Systemic Therapy by
Scott Henggeler.[12]
These interventions were selected for three reasons: They went through a similar product
development cycle from initial trials in the 1980s to global dissemination in the last 10 years;
they are professionally disseminated in multiple service settings (e.g. clinical, public health,
youth justice, early childcare) in multiple countries; and in all four cases the developers have
some financial conflict of interest.
Triple P is a system of standardized parenting support interventions based on social learn-
ing and cognitive-behavioral principles.[9] It is one of the most widely evaluated parenting
programmes worldwide. The evidence-base for Triple P is controversial. A meta-analysis of
101 studies conducted by authors with a financial conflict of interests concluded that Triple P
has positive effects on a broad range of child, parent, and family outcomes.[9] However, an
independent systematic review found no convincing evidence that Triple P has positive effects
across the whole population or in the long run.[6, 13] Triple P began commercial operations in
1996. In 2001 the University of Queensland granted the worldwide dissemination license to the
private company Triple P International (TPI).[14] About seven million copies of group-based
standard Triple P have been sold in 18 languages across 25 countries, and over 62,000 providers
have been licensed.[14] The licensing contract between the University of Queensland and TPI
includes the transfer of royalties from the sale of Triple P to UniQuest, which then distributes
them to three groups of beneficiaries: the University of Queensland; the Parenting and Family
Support Centre; and the authors of Triple P.[15] This includes Matthew Sanders, the creator of
Triple P, as the primary recipient. Other authors have contributed specialized versions of Triple
P and are also entitled to royalties. The primary program developer also receives consulting
fees, and his research activities benefit from the sale of Triple P products as one third of the
royalties are paid to his Parenting and Family Support Centre.
Incredible Years is an evidence-based system of interlocking programs that aims to promote
a healthy social and emotional development, to support problem solving abilities, and to reduce
problem behaviors among children aged 0 to 12.[16] It comprises parent training programs,
child programs, and group management programs for teachers and childcare providers. A sys-
tematic review of 50 studies concluded that Incredible Years was effective in improving child
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behavior in a diverse range of families.[17] Since it was first introduced in 1987, Incredible
Years has diversified the age range it serves. Over 30,000 staff have been trained in IY world-
wide, and the program is currently available in 24 countries.[18] It is disseminated through a
private company, Incredible Years, Inc. The CoI arrangements are unusual in that Carolyn
Webster-Stratton, the initiator and main program developer of IY, has voluntarily distanced
herself from activities that could potentially bias the research findings throughout the period of
her academic affiliation with the University of Washington. The arrangement is described as
follows in the standard CoI disclosure: “Dr. Webster-Stratton has disseminated these treat-
ments and stands to gain from favorable reports. Because of this, she has voluntarily agreed to
distance herself from certain critical research activities, including recruitment, consenting, pri-
mary data handling, and data analysis. The University of Washington has approved these
arrangements.“[19]
The Nurse Family Partnership (NFP, known in the USA as the Family-Nurse Partnership)
is an intensive evidence-based home visitation program for low-income first-time mothers.
The program begins during pregnancy and continues for the first two years following birth. It
aims to help mothers improve their prenatal health, supports parents’ early care of their chil-
dren, and assists mothers with subsequent planning of education and work. NFP was initially
developed by David Olds in the 1970s.[20] Studies conducted in the United States suggest posi-
tive effects of the programme on parental care, a reduction in child maltreatment, improve-
ments in the maternal life-course.[21, 22] A recent replication study in England found no
additional benefit over services as usual on the primary outcomes.[23] The Nurse Family Part-
nership has grown enormously since the initial research in the 1970s and 1980s. It is currently
available in over 40 states of the USA and is implemented in six countries internationally. In
2003 the Nurse-Family Partnership National Service Office, a non-profit organization, was
established. It facilitates replication of the NFP program across the US and provides agencies
with support in nursing education, program quality assurance, marketing, and public policy.
The developer does not receive personal remuneration from the licensing of the program.
However, the University of Colorado Denver receives funds from the licensing and some of
these funds go to the Prevention Research Center for Family and Child Health (PRC), directed
by Dr. Olds. The mission of this research centre is to conduct research on the NFP. Also, uni-
versity salaries of academic staff, including that of the salary of the program developer, are
partly funded through the contract between the University of Colorado and the Nurse-Family
Partnership National Service Office.[24]
Multisystemic Therapy (MST) is an intensive family-focused and community-based treat-
ment program for chronic and violent delinquent adolescents. It was originally developed by
Scott Henggeler in the late 1980s and adopts a socio-ecological approach.[25] Various trials
suggest that Multisystemic Therapy is effective for decreasing delinquency and other external-
izing behaviors including substance use, and in reducing the likelihood of out-of-home place-
ment.[26] In the past 15 years MST has been increasingly disseminated internationally. MST is
currently available in 34 US states, 15 countries worldwide, with 23,000 young people treated
each year. In 1996 MST Services was founded as a private for-profit company that oversees the
worldwide dissemination of the program and provides supervision to clinicians. MST Services
has an exclusive license from the Medical University of South Carolina for intellectual prop-
erty. The main program developer is a member and stockholder of MST Services.[27]
No prior study has examined the extent to which journal articles on commercially dissemi-
nated psychosocial interventions and co-authored by programme developers fully disclose con-
flicts of interests, and how journals in the health and psychosocial disciplines process requests
to examine suspected undisclosed CoI in a published article. The present article addresses this
issue by examining all articles relating to four major psychosocial interventions published
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between 2008 and 2014. It aims to provide empirical findings about the extent to which COI
disclosures in the field of psychosocial interventions are complete, and the ways in which edi-
tors respond to requests to examine potentially missing or incomplete COI disclosures.
Methods
The present study entailed two stages. The first stage relied on data in the public domain. It
entailed the retrieval of all relevant articles in peer-reviewed journal articles co-authored by the
programme developer and the coding of COI disclosures. The second stage entailed contacting
editors in all situations where a COI disclosure had been coded as absent, potentially wrong or
incomplete, and the coding of the editors’ responses.
All articles co-authored by the primary program developers and published in English
between January 2008 and July 2014 were examined. 2008 was chosen as the start year because
the first COPE guidance for responding to undisclosed CoI was published in 2006.[8] We
assumed that by 2008 these rules were widely in force. COPE guidance rather than guidance by
other professional bodies such as the International Committee of Medical Journal Editors
(ICMJE) was used because we anticipated that much research on psychosocial interventions
would be published in the fields of prevention science, psychology, nursing, education sciences,
criminology and public health—areas where journals are probably most likely to be members
of COPE.
Google Scholar, PubMed and web-based CVs were used to find all publications co-authored
by the four developers, using the names of the authors as the search criterion. Two research
assistants were given written instructions about data retrieval and initial coding. They read all
articles that could be located, and recorded information relevant for determining a potential
CoI on a Microsoft Excel coding sheet. Where present, CoI disclosures were recorded. A total
of 176 publications were retrieved (S1 Data). In a next step we determined whether a publica-
tion required a CoI statement: Publications were coded as potentially requiring a CoI statement
if they relate to the registration, design, or findings of pertinent trials; if they were overviews of
the empirical or theoretical bases of the intervention; or if they discussed research on provider
training and implementation. Research assistants conducted the initial coding. All coding was
reviewed by the first author of this study. The coding of doubtful cases was resolved through
joint deliberation. In a few cases it was determined that it was unclear whether the article
related to a program or a program component, and a CoI disclosure was therefore appropriate.
These cases were coded as potentially requiring a CoI disclosure at this stage, and were hence
included for further clarification in the second stage of the analysis.
We then coded whether publications adequately reported a CoI. The operational definitions
for the classification used in this study are reported in S1 Appendix. Subsequently we refer to
code labels used there. Articles were coded as disclosing a conflict of interest and not requiring
a contact with the editor if they provided information about whether income from the program
dissemination contributes to research by the developer, information about royalties or consult-
ing fees paid to the developer, or information about developer ownership of the disseminating
company (code C). For all publications that required further clarification we distinguished
three categories: Papers with no CoI disclosure statement (code D1), articles that actively
reported “no financial conflict” without any qualification (code D2), and articles that had either
unclear CoI statements or contradictory information (code D3). For example, some disclosures
stated “the authors report no financial conflict”, but went on to report relevant financial
arrangements in the disclosure text.
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In the second stage of the study we contacted journal editors about missing or incomplete
CoI statements, asked for clarification about the journal’s CoI policy, and requested that publi-
cation of an erratum be considered in line with COPE guidance.
Between July 2014 and July 2015 the first three authors of this study contacted the editors of
journals where an intervention-related paper had been published without a CoI disclosure. The
email listed the articles deemed problematic, described the nature of the financial CoI of the
program developer, and requested clarification of the situation, including a ‘corrigendum’ or
‘erratum’ if appropriate. It also referred to the journal’s CoI policy if such a policy was specified
in the author instructions.
Progress was monitored by means of a Microsoft Excel tracking sheet, and the final outcome
was coded. Codes were developed to reflect the main types of outcomes. Four reasons for non-
publication of an erratum were distinguished, namely a) the editor reported that the journal did
not have a CoI disclosure policy when the manuscript was processed (code E1); b) the editor
examined the issue with the authors and reported that we had erroneously assumed the presence
of a CoI, for example because the examined treatment was not part of the disseminated program
(Code E2), c) the editors were unwilling or unable to examine the issue, for example because the
relevant documents were no longer available or they requested that we contact the authors
directly (code E3), d) we did not obtain a response after at least three reminders (code E4).
Reminders were generally sent out 2–4 weeks after the initial contact or a preliminary response,
but took into consideration ‘out of office’ notices or announcements by editors of when we could
expect a response. We waited for up to 30 days for an initial response by the editor.
Two reasons for the eventual publication of an erratum or corrigendum were distinguished:
The first refers to cases where the editors discovered an error in the original handling of the
manuscript, which then led to the erroneous non-publication of a submitted CoI disclosure
(code F1). The second group refers to cases where the editor contacted the authors and a new
or revised CoI disclosure was submitted for publication as an erratum (code F2).
Variables associated with CoI disclosure
We also examined five variables that may be associated with the likelihood that a CoI is dis-
closed: First, to examine whether there was a trend towards more CoI disclosures since the
introduction of COPE guidance two periods were distinguished, namely 2008–11 and 2012–
14. Second, we examined whether the affiliation of a journal to the Committee of Publication
Ethics COPE influenced CoI reporting. Coding was based on the most current list of COPE
members and may not necessarily have been correct at the time of the publication of the article.
Journals that are not members of COPE may be members of other associations such as the
American Psychological Association that have their own ethical standards for editors in con-
nection with CoI disclosure. Third, because the first authors often are responsible for submit-
ting all details related to a publication, a dummy variable was formed to measure whether the
program developer was the first author or not. Fourth, we coded whether journals had a pub-
lished and compulsory CoI disclosure policy for authors at the time the article was published.
Published author instructions were screened to determine whether the journal requested the
disclosure of CoI. Journals were coded as not having a published disclosure policy if no such
request was included in the author instructions or if the journal editor informed us that no
such policy had been in place when the article had been published. Finally, we coded whether
the subject area of the journal was predominantly in psychiatry, pediatrics and the medical sci-
ences or not. The reason was that the medical field probably began to address the issue of
undisclosed CoI and potential research bias associated with CoI earlier than psychology and
the prevention sciences.
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Ethics statement
The first stage of the study used data that are in the public domain. For the second stage the
journal editors were contacted in their professional role as representatives of the journal.
Authors of this article contacted the journal editorial offices in their role as users of academic
research, requesting that a missing CoI disclosure be examined in line with COPE guidelines.
At this stage the authors did not disclose to the journal editors that their responses could subse-
quently be used for research purposes. This approach is based on the argument that journal
editors respond to reader requests in a public role, providing a public service to the research
communities they serve. In such situations researchers can legitimately put themselves in the
position of service users, ‘mystery shoppers’, or academic citizens.[28] All journal editors were
debriefed after the completion of the study, including full information about the study purpose
and all findings presented in this article. The debriefing included an invitation to comment on
the findings and a request for consent to the inclusion of the journal responses in the study.
Two journal editors representing two publications requested that their decisions were not
included in the study. The procedure was approved by the ethics committee of the Institute of
Criminology of the University of Cambridge.
Results
Table 1 shows summary statistics for the 176 articles published in 90 different journals. The
most frequent subject areas of the journals were pediatrics, psychiatry, clinical psychology,
counseling and family studies, prevention science, and public health. Initial screening showed
that 40 (23.9%) of the publications were not related to the psychosocial interventions under
examination or could not be found, for example because the journal had ceased to exist
(Table 1). The remaining 136 publications (77.1%) were assessed as potentially intervention-
related and hence requiring a CoI statement (Table 1). Two editors wished not to be included
in the study. The sample available for analysis was therefore 134 articles in 73 journals. Of
these 51% (n = 68) had been published in 2012–2014: 67% (n = 90) of articles had been pub-
lished in a journal that was a COPE member at the time of the publication; the program
Table 1. Summary Statistics for retrieved articles, program related articles, and criteria examined for
association with COI disclosure.
n
Retrieved articles
Articles co-authored by program developer, Jan 2008–July 2014 176
Different journals 90
Of which journals retracted from study (no informed consent) 2
Articles available for analysis 174
of which not related to program 40
Sample included in study
Program-related articles 134
Different Journals 73
Criteria examined for association with COI disclosure
Published Jan 2012–Jul 2014 68
Journal is a COPE member “YES” 90
Program developer is the ﬁrst author 44
Journal has published COI disclosure policy 44
Journal discipline psychiatry, pediatrics and medical science 23
doi:10.1371/journal.pone.0142803.t001
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developer was the first author in 32% (n = 44) of the articles; the journal had a published COI
disclosure policy in 32% of the articles and 17% (n = 23) of the articles had been published in
journals that are predominantly related to the medical sciences.
Table 2 shows the main results for the relevant articles. The majority of publications, namely
59%, related to Triple P. Ten percent related to NFP, 19% to MST, and 12% to IY. Editors of 58
journals were contacted in connection with n = 92 articles. The most frequent subject areas of
the journals were pediatrics, psychiatry, clinical psychology, counseling and family studies, pre-
vention science, and public health.
Overall, 42 publications were assessed as having adequate CoI disclosures in the initial stage
of the study. Subsequent responses by editors showed that three publications attributed to
MST were unrelated to the psychosocial intervention and were therefore removed from the rel-
evant calculations (code E4). One CoI disclosure related to Triple P that we had considered
incomplete was found to have been adequate by the group of editors. It was therefore reclassi-
fied for the analyses. Taking these changes into account the overall rate of adequate CoI disclo-
sures was 32%. There were significant differences in disclosure rates between programs, χ2 (3,
N = 132) = 42.5, p = .00001. Disclosure rates were 11% (Triple P), 57% (NFP), 73% (MST) and
63% (IY). Post hoc analyses showed that disclosure rate for Triple P differed from the disclo-
sure rate of NFP (χ2 (1, N = 93) = 16.7, p = .00005), of MST (χ2 (1, N = 101) = 34.7, p = .00001)
and of IY (χ2 (1, N = 95) = 21.7, p = .00001). No other difference was statistically significant.
We contacted editors in connection with n = 92 articles. In the majority of publications (81/
92, 86%) the editors were contacted because there was no CoI disclosure. In five cases the jour-
nal was contacted because a CoI disclosure stated that the authors actively reported no conflict
Table 2. Publications in peer-reviewed journals with and without CoI disclosures, four internationally disseminated psychosocial interventions,
Jan 2008–July 2014.
Row1 Characteristic Triple P NFP MST IY Total
B Included in analysis 79 14 25 16 134
C COI fully disclosed, editor not contacted 8 8 16 10 42
D Editor contacted 71 6 9 6 92
D1 CoI disclosure missing 60 4 9 6 79
D2 "No conﬂict of interest" statement 4 1 0 0 5
D3 Ambiguous or incomplete disclosure 7 1 0 0 8
E No erratum/corrigendum published 13 5 6 2 26
E1 No disclosure policy 11 3 1 1 16
E2 Not program paper–journal/author response 0 0 3 0 3
E3 CoI deemed sufﬁcient 1 0 0 0 1
E4 Unable/unwilling to examine 1 2 1 1 5
E5 No ﬁnal response 1 0 1 0 2
F Erratum/corrigendum announced 57 1 3 4 65
F1 Journal mishandling 14 0 2 0 16
F2 Authors submit corrected or new CoI 43 1 1 4 49
Rates
Disclosure rate2 11% 57% 73% 63% 33%
Errata rate3 80% 17% 33% 67% 71%
Notes
1 See S1 Appendix for coding scheme and operational deﬁnitions.
2 Calculated as (C+E3)/(B-E2).
3 Calculated as F/D.
doi:10.1371/journal.pone.0142803.t002
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of interests. Editors were also contacted in connection with eight papers in which the informa-
tion provided was ambiguous or incomplete. In four of these cases the financial disclosure
reported ‘no financial conflict’ while the more detailed statement allowed the reader to infer
that the company pays royalties to the authors. In other cases the statement reported that the
program is disseminated commercially, but it is impossible for the reader to understand the
link with the authors’ personal financial interests.
In 26 cases no correction was made. Reasons why no correction was made varied: In half of
the publications (n = 16) the editor reported that the journal had no CoI disclosure policy at
the time of the publication. For three papers the journal consulted with the authors and
reported that we had wrongly assumed that the article required a CoI disclosure. The reason
was that the articles discussed a generic intervention strategy rather than an element of the
intervention with which the authors had a CoI. In one case an existing CoI disclosure was con-
sidered to be satisfactory. In five cases the editors responded but were unable or unwilling to
examine our request because, for example, the documents pertaining to the submission were
no longer available, a different editor had been responsible for the review process at the time,
or the publication of a CoI in a different journal was deemed sufficient. In three cases no
response could be obtained despite three reminders.
Overall, the majority of contacts with a journal (71%, n = 65) led to an erratum, corrigen-
dum, or addendum. For sixteen of these articles, published in nine different journals, the edi-
tors reported failures by the journal in the processing of the submitted disclosure: In fourteen
cases a correct CoI disclosure had been submitted with the manuscript, but the disclosure had
inadvertently been omitted. In one case the authors had correctly disclosed their conflicts of
interests, and the additional statement ‘the authors declare no conflict of interests’ had been
included in error.
In the remaining 49 cases the journal editors contacted the authors to request a clarification.
In every case the authors responded and submitted a new or revised conflict of interest state-
ment. This included six of the seven cases where the initial CoI disclosure actively stated that
the authors declared no conflict of interests. The likelihood that a request to a journal resulted
in an erratum varied between the programs, χ2 (3, N = 91) = 18.7, p = .00031. 80% of all Triple
P publications resulted in an erratum. In contrast, only one of the six FNP papers where we
had contacted the journal led to an erratum or corrigendum.
Variables associated with CoI disclosure
We conducted secondary analyses on five variables that may be associated with the likelihood
of a full CoI disclosure among those that require a disclosure. The percentage of articles with a
CoI disclosure increased slightly from 28% to 36% between 2008–11 and 2012–14. This differ-
ence was not statistically significant, χ2 (1, N = 132) = 1.54, p = .21. Articles with the program
developer as the first author had a higher disclosure rate than others (42% versus 28%) but
again this difference was not significant, χ2 (1, N = 132) = 2.02, p = .15. Articles published in
journals that are members of COPE were significantly less likely to have a CoI disclosure than
articles published in other journals (23% versus 50%), χ2 (1, N = 132) = 10.72, p = .001. If a
journal had a explicit disclosure policy the probability of disclosure was 40% as opposed to
16% in journals that had no such policy, χ2 (1, N = 132) = 9.00, p = .003. Finally, results sug-
gested that the likelihood of a CoI disclosure was more than twice as high if the article had
been published in a medical sciences journal than in the other journals (57% versus 27%), χ2
(1, N = 132) = 7.27, p = .008.
We also examined variation in the probability that our request resulted in an erratum or
corrigendum among those publications for which we had contacted the editors and that
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potentially required a CoI (i.e. excluding categories E2 and E3, Table 1). Between the two peri-
ods (2008–11 and 2012–14) we found a small and non-significant increase in the proportion of
errata from 70% to 76%, χ2 (1, N = 88) = 0.70, p = .40. The chances that editors would publish
an erratum were also higher if the program developer was not the first author (75%) than if the
program developer was the first author (63%), but the difference was not significant, χ2 (1,
N = 88) = 2.20, p = .14. Whether a journal was a member of COPE or not did not affect the
probability of an erratum (74% versus 68%, χ2 (1, N = 88) = 0.04, p = .70. Journals that had
a published CoI policy were much more likely to respond with an erratum (90%) as compared
to those who did not have such a policy (49%), χ2 (1, N = 88) = 21.03, p = 0.00001. Finally,
medical journals were more likely to publish an erratum as a response to our request (90%)
than non-medical journals (70%), but the difference was not significant, χ2 (1, N = 89) = 1.52,
p = .22.
Discussion
The proportion of articles in peer-reviewed journals that fully disclose a personal or organisa-
tional financial CoI of the program developer was 33% among four internationally dissemi-
nated psychosocial interventions with a strong parenting support or training component. The
average rate of disclosure found for these psychosocial interventions was lower than rates
found in recent similar studies of pharmaceutical trials. A study on CoI disclosures among phy-
sicians found that 45.5% of publications by physicians who had obtained payments by pharma-
ceutical companies reported a financial CoI.[29] A study of 100 drug trial reports among
Danish physicians found that almost half reported some financial CoI.[30]
However, we also found significant variation in the disclosure rates between the interven-
tions, ranging from 11% to 70%. The reasons for this variation between the programs are not
clear. The responses by the journal editors shed some light on where the responsibility for
missing or incomplete CoI disclosures may lie. Specifically, 26% of all announced errata were
found to result from a handling error on the part of the journal, whereby a submitted CoI dis-
closure had not been processed appropriately. This includes disclosures that were not pub-
lished at all as well as disclosures where sections were erroneously inserted. It is difficult to
assess this figure as we are not aware of any other study that has collected comparable data.
However, the proportion seems high. It suggests that improved processing of disclosures at the
editorial level as well as authors’ attention to completeness of the article proofs could contrib-
ute to increased transparency. At the same time, 74% of all errata (n = 46) are linked to publica-
tions where the authors had either not followed the journals’ guidance for CoI disclosure or
submitted a disclosure that the editors considered incomplete in the light of our request. How-
ever, for the program with the lowest disclosure rate (Triple P) we found both more cases that
had been mishandled by the editorial office and more cases where the authors were requested
to submit a new or corrected CoI disclosure.
Recent studies have reported some improvement in levels of transparency about CoI as a
result of the growing adoption and implementation of disclosure mechanisms, primarily in the
medical sciences. [31] [32] In this study we found a slight and non-significant increase in dis-
closure rates since 2008. This may indicate some partial success of the efforts by COPE and
other bodies that promote transparency in research. However, the findings also suggest that
much remains to be done. Further analyses by subgroups suggest that more systematic controls
can help further ameliorate the situation. In particular, we found that disclosure rates were sig-
nificantly higher in journals with a published CoI disclosure policy and in journals in the medi-
cal sciences, where standards for CoI disclosure have been raised significantly over the past 10
years, amongst others through the introduction of the ICMJE conflict of interests disclosure
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form.[33] Journals that were COPE members had lower disclosure rates than journals that
were not. A likely explanation for this surprising finding is that many non-members of COPE
included in this study are journals published either by the APA or the American Medical Asso-
ciation (AMA). Journals published by these professional organizations may have promoted
high standards of CoI disclosure somewhat earlier than was the case in many journals that are
COPE members.
When contacted about missing or contradictory CoI statements, journal editors were gener-
ally responsive to our requests and reacted broadly in line with COPE guidance: In only 8% of
all contacts we were unable to obtain a final response or the editor was unable to deal with our
request.
Additional effects
The n = 65 errata that were published as a result of our requests can be interpreted as an inter-
vention effect. Additionally, the present study had several positive effects that are not easily
quantified. One journal with no CoI policy prior to the intervention introduced such a policy
as a result of the intervention. Another journal reported that it had made major changes to its
CoI disclosure policy and the internal processing mechanisms as a result of our intervention. A
further journal endorsed advice about possible ways to minimize the risk of non-disclosure in
the future. Finally, the developer of one of the examined interventions publicly acknowledged
our role in changing the way conflicts of interests are managed across the program.[34]
Strengths
This is the first study that has systematically examined CoI disclosure for commercially dissem-
inated psychosocial interventions. It is also the first study that examines editor compliance
with COPE guidance about proper procedures, when problems are drawn to their attention.
The methodological approach of contacting the journal editors provided valuable information
about the responsiveness of journals to reader requests. The study also sheds some light on
where the responsibility for missing CoI statements lies.
Limitations
The observational part of the present study was limited to a convenience sample of four com-
mercially disseminated psychosocial interventions with a strong parenting component and
where there was prior published evidence of financial conflicting interests. It is not known to
what extent these findings can be generalized to the wider population of psychosocial interven-
tions. Also, no information could be obtained about why authors failed to submit CoI
disclosures.
Conclusions
Systematic reviews and meta-analyses consistently show a positive association between
reported effect sizes and a CoI of the study authors.[3, 35, 36] Therefore practitioners, research-
ers and policy makers in public health increasingly expect transparency about conflicts of inter-
ests in academic research. Transparency about CoI in itself does not necessarily improve the
quality of research, and researchers with a CoI should not be presumed to conduct less valid
scholarship.[37] But transparency is a necessary component for readers to assess the study
findings and their context. This study suggests that consumers of research on psychosocial
interventions cannot expect that CoI disclosures are adequate and complete at present.
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This is due, in part, to the absence of CoI disclosure guidelines in some scientific journals.
This gap can be closed by encouraging all journals to adopt CoI disclosure policies that are
widely published. Standardized and comprehensive CoI forms are an additional strategy to
support compliance with published policies.[38, 39] Also, editors of nine journals reported
handling errors of a submitted disclosure. Additional measures are therefore needed to
improve the handling of disclosures at the level of editorial offices. Failsafe systems for CoI sub-
mission such as the ICMJE uniform disclosure formed at the point of paper submission could
help minimize missing and contradictory CoI disclosure.[40]
However, the substantial variability in disclosure rates suggests that much responsibility
seems to lie with the authors. The lack of transparency about authors’ reporting of COI has
implications for systematic reviews in the field of psychosocial evaluations. The high rate of
undisclosed COI found in the present study suggests that research syntheses relying on pub-
lished information risk underestimating the extent of COI, and hence cannot reliably assess the
possible association between COI and reported intervention effects. So far only one study has
examined the issue in the field of psycho-social interventions.[41] It found a substantial associ-
ation between an indicator that measured COI independently of the actual disclosure and the
reported effect sizes.
Several measures may help to improve author compliance with standards of CoI disclosure.
Universities may more actively provide support for compliance with guidance about managing
CoI. To avoid inadvertent breaches of CoI guidance authors and co-author should carefully
check the material at all stages of the publication process for completeness.
Finally, the present findings show that the mechanisms developed by COPE for rectifying
missing CoI disclosures are generally effective, if readers document these breaches and contact
editors. However, it is unknown how often readers contact editors outside the context of this
study, and whether readers of the articles access the errata. Most journal editors were respon-
sive to our requests to examine missing CoI statements. In every case where the journal editors
followed our request and contacted the authors of the paper, to their credit the authors com-
plied and submitted a correction which led to an ‘erratum’. Second, new developments such as
the CONSORT extension for interventions in public health and related disciplines will likely
contribute to enhance standard of reporting in the field of psychosocial interventions.[42]
Requirements about the disclosure of CoI have been in place for many years in most jour-
nals. This study examined disclosure of financial interests in situations where developers of
commercially disseminated psychosocial interventions have a personal or organizational CoI.
It found that disclosure rates are low and that disclosure rates vary between different interven-
tions. As more commercial psychosocial programs appear on the market it is important that
systems for effective transparency are implemented to ensure that research consumers and
clinical commissioning bodies are aware of potential research biases. The field of biomedical
research has optimized such systems throughout the last decade, yet our findings suggest that
closer attention must be paid to these issues in psychosocial interventions.
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